Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.
Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.
In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...
Hosted on MSN
Une avancée majeure contre le cancer de la prostate : un nouveau traitement réduit le risque de décès de 40%
Nous allons parler d’une nouvelle vraiment encourageante pour les hommes qui luttent contre un cancer de la prostate tenace. Vous savez, parfois, même après une opération ou des rayons, la maladie ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
A real-world analysis suggests that achieving a prostate-specific antigen (PSA) level < 0.2 ng/mL within 9 months of starting androgen deprivation therapy (ADT)-based treatments was the PSA benchmark ...
Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...
A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...
Certains cancers de la prostate évoluent si lentement qu'ils ne tueront jamais leur porteur, d'autres imposent d'agir sans tarder, et un seul chiffre de PSA ne permet pas de les distinguer. Entre 45 e ...
Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results